Clin2
NCT06655883Possibly a fitRecruiting

Testing suvorexant for insomnia in people with opioid use disorder

Insomnia

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests whether the sleep medication suvorexant (Belsomra) can help people with opioid use disorder who also have trouble sleeping. If you are stable on medication for opioid use disorder and have not used opioids in the last month, this trial may be an option for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
300 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You have been diagnosed with opioid use disorder and are on a stable dose of medication to treat it (like methadone or buprenorphine).
  • You have chronic trouble sleeping (insomnia) for at least a month.
  • You have not taken any opioid drugs for at least 4 weeks before the study starts.
  • You do not have other serious sleep disorders (like sleep apnea, restless legs, or narcolepsy) or an unstable mental health condition.
  • Your usual bedtime is between 8 PM and 1 AM, and you can keep that schedule during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06679062Recruiting· Phase 2
Suvorexant for alcohol use disorder and PTSD

This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.

Los Angeles, California
NCT07686731Not yet recruiting· Phase 4
Testing suvorexant for sleep and PTSD in veterans

This study tests if the sleep medication suvorexant can improve both sleep and PTSD symptoms in veterans. If you have PTSD and insomnia, and you are a veteran, this might be a treatment option for you.

San Francisco, California
NCT06981195Recruiting· Phase 2
Testing lemborexant for insomnia in people on buprenorphine

This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.

Richmond, Virginia
NCT06788522Not yet recruiting· Phase 4
Testing a sleep medication to help with PTSD

This study tests if a medication that blocks a brain chemical called orexin can help people with PTSD sleep better and reduce fear. You must have chronic PTSD, trouble sleeping, and be a U.S. military veteran.

San Francisco, California
NCT07701928Not yet recruiting· Phase 2
Daridorexant for sleep and alcohol use disorder

This trial tests if the sleep medication daridorexant can help people who have both insomnia and alcohol use disorder. It looks at whether the drug improves sleep and reduces drinking.

Spokane, Washington
NCT07417813Recruiting
Lemborexant for insomnia in people with mental health conditions

This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.

Suzhou, Jiangsu

Hear when a new Insomnia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.